Review Article
No access
Published Online: 24 November 2020

The Effects of Intermittent Fasting on Glycemic Control and Body Composition in Adults with Obesity and Type 2 Diabetes: A Systematic Review

Publication: Metabolic Syndrome and Related Disorders
Volume 18, Issue Number 10

Abstract

The purpose of this study was to evaluate the effects of intermittent fasting on glycemic control and body composition in adults with obesity and type 2 diabetes. Although intermittent fasting has shown some promise in improving glucoregulatory indicators and body composition in adults with obesity, there is currently no systematic review evaluating these effects in adults with obesity and type 2 diabetes. A database search of PubMed, CINHAL, and MEDLINE identified five studies that met inclusion criterion. All studies were randomized controlled trials in adult subjects (n = 46–137) with type 2 diabetes and a body mass index of ≥30 kg/m2. Four different intermittent fasting regimens were reviewed. All fasting regimens revealed strong evidence to support intermittent fasting as a feasible diet to improve glycemia and body composition measures within 12–24 weeks. Follow-up 12–18 months after intermittent fasting did not show promising results for continued weight loss and improved glycemic control. The majority of the studies demonstrated insignificant differences between intermittent fasting and continuous energy restriction for measures of glycated hemoglobin a1c and body composition. More data on intermittent fasting in adults with obesity and type 2 diabetes are needed to determine its benefits within this patient population. Future research should include consistent fasting regimens and larger sample sizes to improve the reliability and generalizability of the data. Also, consistent follow-up after a fasting intervention may enhance long-term benefits and should be considered in future research.

Get full access to this article

View all available purchase options and get full access to this article.

References

1. Hurt RT, Kulisek C, Buchanan LA, et al. The obesity epidemic: Challenges, health initiatives, and implications for gastroenterologists. Gastroenterol Hepatol (N Y) 2010;6:780–792.
2. CDC. Obesity and overweight. Updated April 1, 2020. Accessed at https://who.int/news-room/fact-sheets/detail/obesity-and-overweight on February 25, 2020.
3. CDC. Adult obesity facts. Updated June 29, 2020. Accessed at https://cdc.gov/obesity/data/adult.html on February 22, 2020.
4. Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med 2019;381:2440–2450.
5. CDC. National diabetes statistics report 2020. Estimates of diabetes and its burden in the United States, 2020. Accessed at https://cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf on February 23, 2020.
6. Johnson EL, Feldman H, Butts A, et al. Standards of medical care in diabetes—2020 abridged for primary care providers. Clin Diabetes 2020;38:10–38.
7. Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes Targets Ther 2014;7:587–591.
9. World Health Organization. Obesity and overweight, 2003. Accessed at https://who.int/dietphysicalactivity/media/en/gsfs_obesity.pdf on February 25, 2020.
10. Turner N, Cooney GJ, Kraegen EW, et al. Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J Endocrinol 2014;220:T61–T79.
11. Chadt A, Scherneck S, Joost H-G, et al. Molecular links between obesity and diabetes: “Diabesity.” MDText.com, Inc., 2000. Accessed at https://ncbi.nlm.nih.gov/sites/books/NBK279051/ on February 22, 2020.
12. Evert AB, Dennison M, Gardner CD, et al. Nutrition therapy for adults with diabetes or prediabetes: A consensus report. Diabetes Care 2019;42:731–754.
13. Franz MJ, Boucher JL, Rutten-Ramos S, et al. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet 2015;115:1447–1463.
14. Norris SL, Zhang X, Avenell A, et al. Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: A meta-analysis. Am J Med 2004;117:762–774.
15. Trepanowski JF, Kroeger CM, Barnosky A, et al. Effect of alternate-day fasting on weight loss, weight maintenance, and cardioprotection among metabolically healthy obese adults: A randomized clinical trial. JAMA Intern Med 2017;177:930–938.
16. Hall KD, Kahan S. Maintenance of lost weight and long-term management of obesity. Med Clin North Am 2018;102:183–197.
17. Seimon RV, Roekenes JA, Zibellini J, et al. Do intermittent diets provide physiological benefits over continuous diets for weight loss? A systematic review of clinical trials. Mol Cell Endocrinol 2015;418:153–172.
18. Harris L, Hamilton S, Azevedo LB, et al. Intermittent fasting interventions for treatment of overweight and obesity in adults. JBI Database Syst Rev Implement Reports 2018;16:507–547.
19. Patterson RE, Laughlin GA, LaCroix AZ, et al. Intermittent fasting and human metabolic health. J Acad Nutr Diet 2015;115:1203–1212.
20. Cho Y, Hong N, Kim K, et al. The effectiveness of intermittent fasting to reduce body mass index and glucose metabolism: A systematic review and meta-analysis. J Clin Med 2019;8:1645.
21. Barnosky AR, Hoddy KK, Unterman TG, et al. Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: A review of human findings. Transl Res 2014;164:302–311.
22. Varady KA. Intermittent versus daily calorie restriction: Which diet regimen is more effective for weight loss? Obes Rev 2011;12:e593–e601.
23. Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: A randomized trial in young overweight women. Int J Obes 2011;35:714–727.
24. Klempel MC, Kroeger CM, Varady KA. Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet. Metabolism 2013;62:137–143.
25. Bhutani S, Klempel MC, Kroeger CM, et al. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity 2013;21:1370–1379.
26. Klempel MC, Kroeger CM, Bhutani S, et al. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr J 2012;11:98.
27. Varady KA, Bhutani S, Church EC, et al. Short-term modified alternate-day fasting: A novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr 2009;90:1138–1143.
28. Varady KA, Bhutani S, Klempel MC, et al. Alternate day fasting for weight loss in normal weight and overweight subjects: A randomized controlled trial. Nutr J 2013;12:146.
29. Eshghinia S, Mohammadzadeh F. The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women. J Diabetes Metab Disord 2013;12:4.
30. Johnson JB, Summer W, Cutler RG, et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 2007;42:665–674.
31. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009;6:e1000097.
32. Kahleova H, Belinova L, Malinska H, et al. Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: A randomised crossover study. Diabetologia 2014;57:1552–1560.
33. Li C, Sadraie B, Steckhan N, et al. Effects of A one-week fasting therapy in patients with type-2 diabetes mellitus and metabolic syndrome—a randomized controlled explorative study. Exp Clin Endocrinol Diabetes 2017;125:618–624.
34. Carter S, Clifton PM, Keogh JB. The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes; a pragmatic pilot trial. Diabetes Res Clin Pract 2016;122:106–112.
35. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension 2020;75:1334–1357.
36. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol 2020;16:223–237.
37. Higgins JPT, Savović J, Page MJ, et al. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds). Cochrane Handbook for Systematic Reviews of Intervention Version 6.0, Chichester, UK: Cochrane; 2019. Accessed at https://handbook-5-1.cochrane.org/chapter_8/8_assessing_risk_of_bias_in_included_studies.htm on April 23, 2020.
38. National Heart, Lung and Blood Institute (NHLBI). Study quality assessment tools. 2014. Accessed at https://nhlbi.nih.gov/health-topics/study-quality-assessment-tools on April 23, 2020.
39. Carter S, Clifton PM, Keogh JB. The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-Month follow-up of a randomised noninferiority trial. Diabetes Res Clin Pract 2019;151:11–19.
40. Ash S, Reeves MM, Yeo S, et al. Effect of intensive dietetic interventions on weight and glycaemic control in overweight men with type II diabetes: A randomised trial. Int J Obes 2003;27:797–802.
41. Furmli S, Elmasry R, Ramos M, et al. Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin. BMJ Case Rep 2018; [Epub ahead of print]; DOI: 10.1136/bcr-2017-221854.
42. Teong XT, Liu K, Hutchison AT, et al. Rationale and protocol for a randomized controlled trial comparing daily calorie restriction versus intermittent fasting to improve glycaemia in individuals at increased risk of developing type 2 diabetes. Obes Res Clin Pract 2020 [Epub ahead of print];
43. Corley BT, Carroll RW, Hall RM, et al. Intermittent fasting in type 2 diabetes mellitus and the risk of hypoglycaemia: A randomized controlled trial. Diabet Med 2018;35:588–594.
44. Arnason TG, Bowen MW, Mansell KD. Effects of intermittent fasting on health markers in those with type 2 diabetes: A pilot study. World J Diabetes 2017;8:154.
45. Kahan BC, Rehal S, Cro S. Risk of selection bias in randomised trials. Trials 2015;16:405.
46. Noakes M, Clifton P (eds.). About the diet CSIRO total wellbeing diet. Accessed at https://totalwellbeingdiet.com/au/the-diet/our-diet/about-the-diet/ on March 20, 2020.
47. Shantha GPS, Kumar AA, Kahan S, et al. Association between glycosylated hemoglobin and intentional weight loss in overweight and obese patients with type 2 diabetes mellitus. Diabetes Educ 2012;38:417–426.
48. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. Atlanta, GA: Centers for Disease Control and Prevention; 2011. Accessed at https://thewrightcenter.org/wp-content/uploads/2013/07/National-Diabetes-Fast-Facts-Part-2-PDF.pdf on June 10, 2020.
49. Maggio CA, Pi-Sunyer FX. The prevention and treatment of obesity: Application to type 2 diabetes. Diabetes Care 1997;20:1744–1766.
50. Glenny A-M, O'Meara S, Melville A, et al. Review: The treatment and prevention of obesity: A systematic review of the literature. Int J Obes 1997;21:715–737.
51. Franz MJ, MacLeod J, Evert A, et al. Academy of Nutrition and Dietetics nutrition practice guideline for type 1 and type 2 diabetes in adults: Systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process. J Acad Nutr Diet 2017;117:1659–1679.
52. Rudenski AS, Hadden DR, Atkinson AB, et al. Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabet Med 1988;5:36–41.
53. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995;44:1249–1258.
54. Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Very low-calorie eiet and 6 months of weight stability in type 2 diabetes: Pathophysiological changes in responders and nonresponders. Diabetes Care 2016;39:808–815.
55. Lean ME, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): An open-label, cluster-randomised trial. Lancet 2018;391:541–551.
56. Zubrzycki A, Cierpka-Kmiec K, Kmiec Z, et al. The role of low-calorie diets and intermittent fasting in the treatment of obesity and type-2 diabetes. J Physiol Pharmacol 2018;69:663–683.
57. Rothschild J, Hoddy KK, Jambazian P, et al. Time-restricted feeding and risk of metabolic disease: A review of human and animal studies. Nutr Rev 2014;72:308–318.
58. Garaulet M, Gómez-Abellán P, Alburquerque-Béjar JJ, et al. Timing of food intake predicts weight loss effectiveness. Int J Obes 2013;37:604–611.
59. Williams KV, Mullen ML, Kelley DE, et al. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care 1998;21:2–8.
60. Heilbronn LK, Noakes M, Clifton PM. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care 1999;22:889–895.
61. Stroebele-Benschop N, Damms-Machado A, Milan FMP, et al. Gender differences in the outcome of obesity treatments and weight loss maintenance - A systematic review. J Obes Weight Loss Ther 2013;03:1–11.
62. Bhogal MS, Langford R. Gender differences in weight loss; evidence from a NHS weight management service. Public Health 2014;128:811–813.
63. McMurray RG, Soares J, Caspersen CJ, et al. Examining variations of resting metabolic rate of adults. Med Sci Sport Exerc 2014;46:1352–1358.
64. Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Adv Nutr An Int Rev J 2017;8:511–519.
65. Kim JE, O'Connor LE, Sands LP, et al. Effects of dietary protein intake on body composition changes after weight loss in older adults: A systematic review and meta-analysis. Nutr Rev 2016;74:210–224.
66. Wycherley TP, Moran LJ, Clifton PM, et al. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: A meta-analysis of randomized controlled trials. Am J Clin Nutr 2012;96:1281–1298.
67. Frimel TN, Sinacore DR, Villareal DT. Exercise attenuates the weight-loss-induced reduction in muscle mass in frail obese older adults. Med Sci Sport Exerc 2008;40:1213–1219.
68. Villareal DT, Chode S, Parimi N, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 2011;364:1218–1229.
69. Noronha JC, Nishi SK, Braunstein CR, et al. The effect of liquid meal replacements on cardiometabolic risk factors in overweight/obese individuals with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabetes Care 2019;42:767–776.
70. Hariton E, Locascio JJ. Randomised controlled trials—the gold standard for effectiveness research. BJOG An Int J Obstet Gynaecol 2018;125:1716.
71. Hackshaw A. Small studies: Strengths and limitations. Eur Respir J 2008;32:1141–1143.
72. Bellissimo N, Akhavan T. Effect of macronutrient composition on short-term food intake and weight loss. Adv Nutr 2015;6:302S–308S.
73. Archundia Herrera M, Chan C. Narrative review of new methods for assessing food and energy intake. Nutrients 2018;10:1064.
74. Dumville JC, Torgerson DJ, Hewitt CE. Reporting attrition in randomised controlled trials. BMJ 2006;332:969–971.

Information & Authors

Information

Published In

cover image Metabolic Syndrome and Related Disorders
Metabolic Syndrome and Related Disorders
Volume 18Issue Number 10December 2020
Pages: 450 - 461
PubMed: 32780629

History

Published in print: December 2020
Published online: 24 November 2020
Published ahead of print: 11 August 2020

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Rosemarie Vitale [email protected]
Nutrition and Dietetics, Central Michigan University, Mount Pleasant, Michigan, USA.
Yeonsoo Kim
Nutrition and Dietetics, Central Michigan University, Mount Pleasant, Michigan, USA.

Notes

Address correspondence to:, Rosemarie Vitale, MS, RDN, Central Michigan University, Nutrition and Dietetics, 1200 South Franklin Street, Mt. Pleasant, MI 48859, USA [email protected]

Author Disclosure Statement

No conflicting financial interests exist.

Funding Information

No funding was received for this article.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top